🏢 官网IRPTCTCodex · 实盘不做把握 9/10
北京时间·🕒 发布 20:00:00时区推断·⟳ 抓取 20:02:10回填·⚡ 决策 07-16 20:04:31·103.0 天前
PTC Therapeutics宣布将于7月30日披露二季度业绩并召开电话会
这只是公司官方发布的业绩披露日程和电话会安排，未包含业绩数据、指引变化、产品进展或监管里程碑。
📄 原文PTCT↗ 原文
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
Skip to main navigation United States Katie, Living with PKU, United States Release Details PTC is committed to serving…
不做 PTC Therapeutics（PTCT.US）
例行财报电话会日程通知，不含业绩数据、指引上修、产品进展或监管结果，无法形成同向可交易 edge，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-16 · 扩散 low · price-in 风险 low ↗
关键理由
- 这只是公司官方发布的业绩披露日程和电话会安排，未包含业绩数据、指引变化、产品进展或监管里程碑。
主要风险
- 若7月30日正式业绩或业务更新出现超预期内容，应由新信号重新研判。
原文全文
展开原文 · 1,996 字
Skip to main navigation
United States
Katie, Living with PKU, United States
Release Details
PTC is committed to serving the interests of all our stakeholders.
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 16, 2026
PDF Version
WARREN, N.J. , July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, July 30, 2026 , at 4:30 p.m. ET .
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of the PTC website . A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advance here to receive dial-in details.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-second-quarter-2026-financial-results-on-thursday-july-30-2026-302826736.html
SOURCE PTC Therapeutics, Inc.
Email Alerts
RSS
Print
United States
Katie, Living with PKU, United States
Release Details
PTC is committed to serving the interests of all our stakeholders.
PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 16, 2026
PDF Version
WARREN, N.J. , July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, July 30, 2026 , at 4:30 p.m. ET .
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of the PTC website . A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advance here to receive dial-in details.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow us on LinkedIn, X, Facebook and Instagram.
For more information, please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/ptc-therapeutics-to-report-second-quarter-2026-financial-results-on-thursday-july-30-2026-302826736.html
SOURCE PTC Therapeutics, Inc.
Email Alerts
RSS
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。